AMGEN
Description
The patients. For them,we research, develop and manufacture innovative therapies against serious illnesses using living resources.This approach is based on cutting-edge technologies, such as human genetics, which make it possible to characterize the molecular mechanisms at the origin of diseases. Amgen focuses its research on pathologies where medical needs remain high .
on French territory since 1990, Amgen today has more than 360 employees spread across France ,20% of whom are dedicated to R&D.
With around 20 drugs and numerous partnership initiatives, Amgen France is working to advance the treatment of cancer, cardiovascular, inflammatory, renal and rare diseases.France is also the 3rd largest subsidiary in terms of Amgen's clinical research activity in the world .
